Tracked deals
24
24 tracked deals across 2016-2026.
Private Equity Firm
Healthcare
Altaris
New York, New York, United States
Altaris is an investment firm exclusively focused on the healthcare industry. It seeks to build market-leading companies that deliver innovation and efficiency to the healthcare system to improve access and outcomes for patients.
- Focus Areas
- Healthcare services, Healthcare technology, Life sciences
- Website
- altariscap.com
Recent pace
6
6 tracked deals announced in the last 12 months.
Deal mix
Buyout
10 buyout · 8 addon · 4 divestiture
Altaris Acquisition Volume by Year
Last 6 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
Showing the 12 most recent of 24 tracked deals for Altaris.
-
October 6, 2026
- Buyer
- Altaris, LLC
- Target
- Clarivate Life Sciences & Healthcare segment
- Seller
- Clarivate Plc
- Industry
- Data & Analytics
- Location
- United States
- Type
- Divestiture
Altaris completed its $600 million acquisition of Clarivate’s Life Sciences & Healthcare segment, a provider of data, analytics, intelligence, software, and services for life sciences and healthcare organizations. Clarivate said the divestiture sharpens its focus on its Academia & Government and Intellectual Property businesses and that it intends to use the proceeds to reduce debt and strengthen its balance sheet.
-
- Buyer
- Altaris, Leidos
- Target
- Leidos Security Enterprise Solutions (SES), Analogic Corporation
- Seller
- Leidos
- Industry
- Manufacturing
- Location
- New Hampshire, United States
- Type
- Divestiture
Leidos and Altaris completed a transaction combining Leidos Security Enterprise Solutions (SES) with Analogic’s security screening business in a U.S.-based joint venture operating under the Analogic brand. Leidos retained a significant minority ownership stake; the combined business brings together screening technologies, engineering expertise, and manufacturing capabilities for airport, border, and critical-infrastructure markets.
-
- Buyer
- Altaris LLC
- Target
- Clarivate Life Sciences & Healthcare segment
- Seller
- Clarivate Plc
- Industry
- Healthcare Services
- Location
- United States
- Type
- Divestiture
Clarivate entered into a definitive agreement to divest its Life Sciences & Healthcare (LS&H) segment to Altaris LLC for $600 million. The deal is structured with $500 million cash at closing, $25 million in cash deferred for a transition services agreement, and a $75 million seller note, with proceeds intended to reduce Clarivate’s debt.
-
June 17, 2026
- Buyer
- Altaris, LLC
- Target
- Simulations Plus, Inc.
- Industry
- Software
- Location
- North Carolina, United States
- Type
- Addon
Altaris acquired Simulations Plus in an all-cash transaction valued at approximately $375 million, with shareholders receiving $18.50 per share. The acquisition was completed on October 6, 2026, and Simulations Plus is being combined with Altaris portfolio company Chemical Computing Group to broaden the combined drug discovery, modeling, and simulation software platform.
-
- Buyer
- Altaris, LLC, Analogic Corporation
- Target
- Leidos Security Enterprise Solutions (SES), Analogic Corporation
- Seller
- Leidos, Inc.
- Industry
- Manufacturing
- Location
- New Hampshire, United States
- Type
- Addon
Altaris-owned Analogic and Leidos agreed to combine Analogic with Leidos’ Security Enterprise Solutions (SES), Ports & Borders, and Industrial Automation businesses, creating a privately held security imaging and detection company under the Analogic brand. Leidos contributed approximately 1,500 employees and retained significant minority ownership; the combination was completed in October 2026.
-
- Buyer
- Altaris, LLC
- Target
- Tegria Services Group, Inc.
- Seller
- Providence St. Joseph Health
- Industry
- Healthcare Services
- Location
- Washington, United States
- Type
- Buyout
Altaris has completed the acquisition of Tegria Services Group, Inc. from Providence St. Joseph Health, establishing Tegria as a standalone, Altaris‑backed portfolio company that will continue to serve Providence as a preferred technology services partner. The deal positions Altaris to expand its healthcare services and technology platform capabilities—supporting providers and payers with consulting, managed services, data & analytics, and revenue cycle management.
-
December 24, 2024
- Buyer
- Altaris, LLC
- Target
- Advanced Therapies (U.S. and U.K. operations of WuXi AppTec's Advanced Therapies Unit), OXGENE
- Seller
- WuXi AppTec
- Industry
- Biotechnology
- Location
- Pennsylvania, United States
- Type
- Addon
Altaris, a New York-based healthcare-focused investment firm, acquired the U.S. and U.K. operations of WuXi AppTec's Advanced Therapies unit (including OXGENE). Advanced Therapies will be renamed and headquartered in the United States and Altaris intends to combine it with its recently acquired Minaris Regenerative Medicine to form Minaris Advanced Therapies, expanding cell-therapy CDMO capabilities and global footprint.
-
September 23, 2024
- Buyer
- Altaris, LLC
- Target
- Minaris Regenerative Medicine
- Seller
- Resonac Corporation, Resonac Holdings Corporation
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Buyout
Altaris, LLC has acquired Minaris Regenerative Medicine from Resonac Corporation, making Minaris a wholly owned portfolio company of Altaris. Minaris is a cell therapy CDMO with six facilities across the United States, Germany and Japan and more than 500 employees; the deal advances Altaris' strategic initiative to build capabilities in cell and gene therapy manufacturing.
-
June 25, 2024
- Buyer
- Altaris, LLC
- Target
- Sharecare, Inc.
- Seller
- Sharecare stockholders
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
Altaris, a healthcare-focused investment firm, agreed to acquire publicly traded digital health company Sharecare in a take-private transaction at $1.43 per share. The deal will take Sharecare private (stockholders approved the transaction) and positions the company to operate as a standalone portfolio company under Altaris to accelerate growth and product/service development.
-
January 18, 2024
- Buyer
- Kindeva Drug Delivery, Altaris, LLC
- Target
- Summit Biosciences, Summit Biosciences Inc.
- Seller
- Summit’s founding family shareholders
- Industry
- Healthcare Services
- Location
- Kentucky, United States
- Type
- Buyout
Kindeva Drug Delivery, an operating company of Altaris, LLC, acquired Summit Biosciences, a specialized intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders. The deal expands Kindeva’s drug-delivery capabilities with a new intranasal drug-delivery platform and adds Summit’s FDA- and EMA-approved cGMP facility in Lexington, Kentucky.
-
April 18, 2023
- Buyer
- Altaris, LLC
- Target
- Trean Insurance Group, Inc.
- Seller
- Trean's remaining public common stockholders
- Industry
- Insurance
- Location
- Minnesota, United States
- Type
- Buyout
Altaris, LLC completed a take-private acquisition of Trean Insurance Group, Inc., acquiring the remaining publicly held shares for $6.15 per share in a transaction that implied an approximate $316 million equity value. Trean will remain headquartered in Wayzata, Minnesota, with Julie Baron continuing as President and CEO and founder Andrew O'Brien remaining as Executive Chairman and an investor; Trean will cease trading on Nasdaq following the closing.
-
December 22, 2022
- Buyer
- Chemical Computing Group ULC, Altaris, LLC
- Target
- Discngine SAS
- Industry
- Software
- Location
- Île-de-France, France
- Type
- Addon
Chemical Computing Group ULC (an Altaris operating company) has acquired Paris-based Discngine SAS, a provider of cheminformatics, structural bioinformatics and lab informatics software and services for life sciences research. The deal will add Discngine as a subsidiary of CCG, bolstering CCG's technical science capabilities and creating synergies across their life-sciences software offerings.
Related Acquisition Pages
Medical Devices Buyers & Acquisitions
8 tracked deals by Altaris.
Healthcare Services Buyers & Acquisitions
5 tracked deals by Altaris.
Manufacturing Buyers & Acquisitions
3 tracked deals by Altaris.
Pharmaceuticals Buyers & Acquisitions
2 tracked deals by Altaris.
Acquisitions in Minnesota
4 tracked deals by Altaris.
Acquisitions in Pennsylvania
3 tracked deals by Altaris.
Acquisitions in Missouri
2 tracked deals by Altaris.
Acquisitions in New Hampshire
2 tracked deals by Altaris.
Selling a company? Get in front of buyers like Altaris
Turn tracked acquisition activity into an outreach-ready buyer list.